Clinical Trial: Melanotan II (MT-II) as an Adjunct to NB-UVB Phototherapy for Repigmentation in Stable Nonsegmental Vitiligo

U.S., Feb. 28 -- ClinicalTrials.gov registry received information related to the study (NCT07437560) titled 'Melanotan II (MT-II) as an Adjunct to NB-UVB Phototherapy for Repigmentation in Stable Nonsegmental Vitiligo' on Feb. 22.

Brief Summary: This example interventional study record describes a randomized Phase 2 clinical trial evaluating investigational Melanotan II (MT-II) as an adjunct to standard NB-UVB phototherapy for repigmentation in adults with stable nonsegmental vitiligo.

Study Start Date: Feb. 02

Study Type: INTERVENTIONAL

Condition: NonSegmental Vitiligo Nonsegmental Vitiligo (Stable)

Intervention: DRUG: Melanotan II (MT-II)

administered per protocol

DRUG: Placebo

matched, administered per protocol.

PROCEDURE: Nar...